Mohamed M Mohyeldin
Overview
Explore the profile of Mohamed M Mohyeldin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
367
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ghallab D, Ibrahim R, Mohyeldin M, Shawky E
Mar Pollut Bull
. 2024 Jan;
199:116023.
PMID: 38211540
This comprehensive review examines the diverse classes of pharmacologically active compounds found in marine algae and their promising anti-inflammatory effects. The review covers various classes of anti-inflammatory compounds sourced from...
2.
ElNagar A, Mohyeldin M, Mostafa N, Salaheldin Abdelhamid Ibrahim S, El-Saber Batiha G, Mahmoud M, et al.
Biomed Pharmacother
. 2023 Oct;
167:115382.
PMID: 37778271
Clivia miniata (Lindl) is a member of the family Amaryllidaceae known for its chemically diverse alkaloids with a wide range of biological activities. Many reports revealed a direct role of...
3.
El Sayed A, El Hawary S, Elimam H, Saleh A, Zokalih A, Mohyeldin M, et al.
Fitoterapia
. 2023 May;
168:105540.
PMID: 37207792
A comprehensive study of leaves, flowers, fruits, bark, and seeds' extracts of Gmelina arborea Roxb was performed for first time to investigate their anti-inflammatory, anti-Alzheimer, and antidiabetic activities. A thorough...
4.
Mohyeldin M, Tarbah A, El-Deeb N, Ghazy N, El-Hawiet A
Nat Prod Res
. 2023 Jan;
37(23):4038-4041.
PMID: 36597612
Herpes simplex virus (HSV) can infect millions of people worldwide causing mild to life-threating infections. The current study demonstrates the first comparative anti-HSV type 1 activity and phytochemical investigation of...
5.
Ghallab D, Shawky E, Ibrahim R, Mohyeldin M
Sci Rep
. 2022 May;
12(1):8094.
PMID: 35577889
Marine algae have served as a treasure trove of structurally variable and biologically active metabolites. The present study emphasizes on UPLC-MS metabolites fingerprinting for the first systematic broad scale metabolites...
6.
Ghallab D, Shawky E, Metwally A, Celik I, Ibrahim R, Mohyeldin M
RSC Adv
. 2022 Apr;
12(5):2843-2872.
PMID: 35425287
Xanthine oxidase (XO) has been well-recognized as a validated target for the treatment of hyperuricemia and gout. Currently, there are two drugs in clinical use that shut down XO overactivity,...
7.
Abdelwahed K, Siddique A, Mohyeldin M, Qusa M, Goda A, Singh S, et al.
Pharmacol Res
. 2020 May;
158:104847.
PMID: 32438039
Hypercholesterolemia has been documented to drive hormone-dependent breast cancer (BC) progression and resistance to hormonal therapy. Proprotein convertase subtilisin/kexin type-9 (PCSK9) regulates cholesterol metabolism through binding to LDL receptor (LDLR)...
8.
Siddique A, Ebrahim H, Akl M, Ayoub N, Goda A, Mohyeldin M, et al.
Nutrients
. 2019 Feb;
11(2).
PMID: 30781364
Dysregulation of epidermal growth factor receptor (EGFR)/human epidermal growth factor-2 (HER2) family is a hallmark of aggressive breast cancer. Small-molecule tyrosine kinase inhibitors are among the most effective cancer targeted...
9.
Souid S, Elsayed H, Ebrahim H, Mohyeldin M, Siddique A, Karoui H, et al.
Mol Carcinog
. 2018 Jul;
57(11):1507-1524.
PMID: 29978911
The failure of chemotherapy especially in triple negative breast cancer (TNBC) patients has been correlated with the overexpression of the mesenchymal-epithelial transition factor (c-Met) receptor. Thus, the hepatocyte growth factor...
10.
Elsayed H, Ebrahim H, Mohyeldin M, Siddique A, Kamal A, Haggag E, et al.
Nutr Cancer
. 2017 Oct;
69(8):1256-1271.
PMID: 29083228
Triple negative breast cancer (TNBC) has high metastatic and mortality potential and lacks effective and selective therapeutic options. Aberrant dysregulation of the receptor tyrosine kinase c-Met promotes TNBC progression, motility...